Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

30.32 +0.26 (+0.86%)

Official Closing Price Updated: 7:00 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

31 32 Next >

Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss ↗

July 27, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.

Via Benzinga

This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

July 27, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital...

Via Benzinga

Teva Pharmaceutical Soars On $75 Million Opioid Deal In West Virginia ↗

July 27, 2022

Teva will also provide the state with free opioid overdose treatment for a decade.

Via Investor's Business Daily

What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today? ↗

July 12, 2022

TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation.

Via InvestorPlace

Analyst Ratings for Teva Pharmaceutical Indus ↗

June 14, 2022

Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings:

Via Benzinga

TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits ↗

July 27, 2022

Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits.

Via InvestorPlace

Why Teva Pharmaceutical Industries Stock Is Soaring ↗

July 27, 2022

Teva Pharmaceutical Industries (NYSE: TEVA) shares are trading higher Wednesday after the company reported better-than-expected financial results.

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Teva Announces $4.25b Opioid Agreement With States, Native American Tribes ↗

July 27, 2022

Teva has reached an agreement in principle with the working group of States' Attorneys General, counsel for Native American Tribes, and plaintiffs' lawyers representing the States and subdivisions, on...

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 27, 2022

Via Benzinga

Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27 ↗

July 27, 2022

Reuters Monkeypox Emergency Could Last Months, According To Experts

Via Benzinga

Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 27, 2022

Pzena Investment Management, Inc (NYSE: PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 27, 2022

Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!

Via InvestorPlace

Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session ↗

July 27, 2022

Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 26, 2022

Gainers

Via Benzinga

Why Teva Pharmaceuticals Stock Is Soaring After Hours ↗

July 26, 2022

Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.

Via Benzinga

Teva Reports Second Quarter 2022 Financial Results

July 26, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

7 Growth Stocks to Buy on the Dip ↗

July 22, 2022

These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns.

Via InvestorPlace

Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1? ↗

July 12, 2022

Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece.

Via InvestorPlace

Teva Reaches Agreement With San Francisco to Settle Opioid-Related Claims

July 12, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report ↗

July 12, 2022

Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY

Via Benzinga

Teva Announces Appointment of New Global R&D and Chief Medical Officer

July 01, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022

June 29, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)

June 24, 2022

From Teva Pharmaceutical Industries Ltd.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022 ↗

June 14, 2022

Upgrades

Via Benzinga

Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

June 09, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

New Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Presented at 2022 American Headache Society Annual Meeting

June 09, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting

June 09, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services

June 08, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Golden Cross Appears Before Teva Pharmaceutical Indus Investors ↗

May 27, 2022

If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.